Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer

During the JADPRO Live Virtual 2020 conference, Val R. Adams, PharmD, FCCP, FHOPA, BCOP, discussed how to determine which patients with cancer should be treated with direct oral anticoagulants (DOACs), the similarities and differences between the DOACs, and recent data on the prevention and treatmen...

Descripción completa

Detalles Bibliográficos
Autor principal: Adams, Val R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087230/
https://www.ncbi.nlm.nih.gov/pubmed/34084571
http://dx.doi.org/10.6004/jadpro.2021.12.3.8
_version_ 1783686629295128576
author Adams, Val R.
author_facet Adams, Val R.
author_sort Adams, Val R.
collection PubMed
description During the JADPRO Live Virtual 2020 conference, Val R. Adams, PharmD, FCCP, FHOPA, BCOP, discussed how to determine which patients with cancer should be treated with direct oral anticoagulants (DOACs), the similarities and differences between the DOACs, and recent data on the prevention and treatment of cancer-associated venous thromboembolism.
format Online
Article
Text
id pubmed-8087230
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-80872302021-06-02 Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer Adams, Val R. J Adv Pract Oncol Meeting Reports During the JADPRO Live Virtual 2020 conference, Val R. Adams, PharmD, FCCP, FHOPA, BCOP, discussed how to determine which patients with cancer should be treated with direct oral anticoagulants (DOACs), the similarities and differences between the DOACs, and recent data on the prevention and treatment of cancer-associated venous thromboembolism. Harborside Press LLC 2021-04 2021-04-01 /pmc/articles/PMC8087230/ /pubmed/34084571 http://dx.doi.org/10.6004/jadpro.2021.12.3.8 Text en © 2021 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Adams, Val R.
Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer
title Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer
title_full Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer
title_fullStr Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer
title_full_unstemmed Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer
title_short Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer
title_sort sticky issues: what aps need to know about anticoagulants and patients with cancer
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087230/
https://www.ncbi.nlm.nih.gov/pubmed/34084571
http://dx.doi.org/10.6004/jadpro.2021.12.3.8
work_keys_str_mv AT adamsvalr stickyissueswhatapsneedtoknowaboutanticoagulantsandpatientswithcancer

Ejemplares similares